BioPharma Resources

Therapeutic area

Ophthalmology

Macular degeneration, diabetic macular edema, glaucoma and dry eye. Drugs are placed in areas by keyword matches on their FDA pharmacologic class and approved use, and trials by their listed conditions, so a few land in the wrong area.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.govMethods & limitations

Approvals since 2023

10

Originals, plus breakthrough or accelerated new uses

Recruiting Phase 2

62

Industry-sponsored

Recruiting Phase 3

44

Industry-sponsored

Recruiting Phase 4 (post-approval)

5

Industry-sponsored

Recent approvals

All
  • Lytenava (Bevacizumab-Vikg) · Outlook Therapeutics, Inc. NovelJul 24, 2026

    To treat patients with neovascular (wet) age-related macular degeneration

  • Differin Epiduo Acne Gel (Adapalene and Benzoyl Peroxide) (Adapalene, Benzoyl Peroxide, Adapalene, Benzoyl Peroxide) · Galderma Labs Lp May 22, 2026
  • Vizz (Aceclidine Hydrochloride) · Lenz Therap NovelJul 31, 2025

    To treat presbyopia

  • Tryptyr (Acoltremon) · Alcon Labs INC NovelMay 28, 2025

    To treat the signs and symptoms of dry eye disease

  • Attruby (Acoramidis Hydrochloride) · Bridgebio Pharma NovelOrphanNov 22, 2024

    To treat cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis

  • Wainua (Autoinjector) (Eplontersen Sodium) · Astrazeneca Ab NovelOrphanDec 21, 2023

    To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis

  • Cabtreo (Adapalene, Benzoyl Peroxide, Clindamycin Phosphate) · Bausch Oct 20, 2023
  • Sohonos (Palovarotene) · Ipsen NovelPriority reviewOrphanAug 16, 2023

    To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva

  • Izervay (Avacincaptad Pegol Sodium) · Astellas NovelBreakthrough therapyPriority reviewAug 4, 2023

    To treat geographic atrophy secondary to age-related macular degeneration

  • Miebo (Perfluorohexyloctane) · Bausch and Lomb INC NovelMay 18, 2023

    To treat signs and symptoms of dry eye disease

Recruiting trials by phase

Industry-sponsored drug and biologic trials.

Most approvals since then, by company

Drugs in development

Investigational drugs in Phase 2 and 3 trials for conditions in this area, most trials first.

All
  • TelitaciceptRC18, RC18-LPhase 38 trials

    RemeGen Co., Ltd. · CTD-ILD, Primary Sjogren's Disease, Sjögren's Disease

  • siRNAADX-038, ADX-324Phase 37 trials

    ADARx Pharmaceuticals, Inc. · Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1

  • MHB018APhase 36 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Thyroid Eye Disease (TED), Thyroid Eye Disease, TED, Thyroid Associated Ophthalmopathies

  • 4D-1503E10 vg, eyePhase 35 trials

    4D Molecular Therapeutics · Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration

  • CemdisiranALN-CC5Phase 35 trials

    Regeneron · Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, Age-related Macular Degeneration (AMD)

  • NPI-001N-Acetylcysteine AmidePhase 35 trials

    Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease

  • TiespectusEYE201, MK-8748Phase 35 trials

    EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization

  • ALXN2220Phase 34 trials

    AstraZeneca · Transthyretin Amyloid Cardiomyopathy (ATTR-CM), Transthyretin Amyloid Cardiomyopathy, Amyloid Transthyretin Cardiomyopathy

  • EYP-1901Phase 34 trials

    EyePoint Pharmaceuticals, Inc. · Diabetic Macular Edema, DME, Diabetic Macular Edema (DME)

  • OLN324Phase 34 trials

    Ollin Biosciences, Inc. · Diabetic Macular Edema (DME), Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration

  • PRL3-ZUMABPhase 34 trials

    Intra-IMMUSG Pte Ltd · Advanced Malignant Solid Tumor, Solid Tumor, Advanced Solid Cancers

  • ALK-001C20-D3-Retinyl Acetate, C20 Deuterated vitamin APhase 33 trials

    Alkeus Pharmaceuticals, Inc. · Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy

  • SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension

  • NNC6019-0001Phase 33 trials

    Novo Nordisk · Transthyretin Amyloid Cardiomyopathy (ATTR CM)

  • OTX-TKIaxitinib implantPhase 33 trials

    Ocular Therapeutix, Inc. · Neovascular Age-related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration (nAMD)

Largest recruiting Phase 3 trials

All

More: Ophthalmology news · literature

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.